Influence of Preoperative Immunomodulation by Oral Impact on Postoperative Complications Following Cystectomies & Nephrectomies
Influence of Preoperative Immunomodulation by Oral Impact® on Postoperative Complications Following Cystectomies and Nephrectomies
Centre Hospitalier Intercommunal Robert Ballanger
214 participants
Nov 30, 2022
INTERVENTIONAL
Conditions
Summary
any studies have shown the benefit of perioperative Oral Impact immunomodulation in gastrointestinal, ENT, gynecological and cardiac surgery. Studies in major Urological surgery are rare and not very contributory. The expected benefit is a reduction in postoperative complications and the average length of stay.
Eligibility
Inclusion Criteria4
- years of age and older
- Scheduled major urological surgery: scheduled: cystectomy, nephrectomy, other laparotomies.
- Having expressed their free and informed consent.
- Affiliated to a social security scheme
Exclusion Criteria7
- Immune deficiency.
- HIV infection.
- Curative surgery for chronic urinary tract infection.
- Urgent surgery.
- Inability to take oral impact 7 days before surgery.
- Unstable psychiatric state.
- Infection with COVID 19 during postoperative stay.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
the group of patients will be received a 7-days course of ORAL IMPACT
no intervention
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05520151